BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Schröder C, Enders D, Schink T, Riedel O. Incidence of herpes zoster amongst adults varies by severity of immunosuppression. J Infect 2017;75:207-15. [PMID: 28676411 DOI: 10.1016/j.jinf.2017.06.010] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Harpaz R. How Little We Know Herpes Zoster. J Infect Dis 2020;222:708-11. [PMID: 31830261 DOI: 10.1093/infdis/jiz653] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
2 Chawki S, Vilcu AM, Etienne C, Finet F, Blanchon T, Souty C, Hanslik T. Incidence of complications of herpes zoster in individuals on immunosuppressive therapy: A register-based population study. J Infect 2022:S0163-4453(22)00003-2. [PMID: 35016899 DOI: 10.1016/j.jinf.2022.01.003] [Reference Citation Analysis]
3 Rondaan C, de Joode AAE, van Assen S, Bos NA, Westerhuis R, Westra J. Increased incidence of herpes zoster in patients on renal replacement therapy cannot be explained by intrinsic defects of cellular or humoral immunity to varicella-zoster virus. Antiviral Res 2018;158:206-12. [PMID: 30102958 DOI: 10.1016/j.antiviral.2018.08.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
4 Kho MML, Roest S, Bovée DM, Metselaar HJ, Hoek RAS, van der Eijk AA, Manintveld OC, Roodnat JI, van Besouw NM. Herpes Zoster in Solid Organ Transplantation: Incidence and Risk Factors. Front Immunol 2021;12:645718. [PMID: 33815403 DOI: 10.3389/fimmu.2021.645718] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Buchan SA, Daneman N, Wang J, Garber G, Wormsbecker AE, Wilson SE, Deeks SL. Incidence of Hospitalizations and Emergency Department Visits for Herpes Zoster in Immunocompromised and Immunocompetent Adults in Ontario, Canada, 2002-2016. Clin Infect Dis 2020;71:22-9. [PMID: 31436814 DOI: 10.1093/cid/ciz769] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
6 Lachiewicz AM, Srinivas ML. Varicella-zoster virus post-exposure management and prophylaxis: A review. Prev Med Rep 2019;16:101016. [PMID: 31890472 DOI: 10.1016/j.pmedr.2019.101016] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
7 Harpaz R. Do varicella vaccination programs change the epidemiology of herpes zoster? A comprehensive review, with focus on the United States. Expert Rev Vaccines 2019;18:793-811. [PMID: 31318605 DOI: 10.1080/14760584.2019.1646129] [Cited by in Crossref: 23] [Cited by in F6Publishing: 14] [Article Influence: 7.7] [Reference Citation Analysis]
8 Imafuku S, Matsuki T, Mizukami A, Goto Y, de Souza S, Jégou C, Bianco V, Rosillon D, Ito C, Curran D, Holl K. Burden of Herpes Zoster in the Japanese Population with Immunocompromised/Chronic Disease Conditions: Results from a Cohort Study Claims Database from 2005-2014. Dermatol Ther (Heidelb) 2019;9:117-33. [PMID: 30456446 DOI: 10.1007/s13555-018-0268-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
9 Spernovasilis N, Milioni A, Gialamas I, Kokorakis E, Fanti G. Varicella-zoster virus meningitis with hypoglycorrhachia in a young immunocompetent adult without rash: A case report and literature review. IDCases 2018;12:104-6. [PMID: 29682449 DOI: 10.1016/j.idcr.2018.04.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
10 Muñoz-Quiles C, López-Lacort M, Díez-Domingo J, Orrico-Sánchez A. Herpes zoster risk and burden of disease in immunocompromised populations: a population-based study using health system integrated databases, 2009-2014. BMC Infect Dis 2020;20:905. [PMID: 33256624 DOI: 10.1186/s12879-020-05648-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
11 Ting SW, Ting SY, Lin YS, Lin MS, Kuo G. Risk of herpes zoster in psoriasis patients receiving systemic therapies: a nationwide population-based cohort study. Sci Rep 2021;11:11824. [PMID: 34083738 DOI: 10.1038/s41598-021-91356-3] [Reference Citation Analysis]
12 Yanni EA, Ferreira G, Guennec M, El Hahi Y, El Ghachi A, Haguinet F, Espie E, Bianco V. Burden of herpes zoster in 16 selected immunocompromised populations in England: a cohort study in the Clinical Practice Research Datalink 2000-2012. BMJ Open 2018;8:e020528. [PMID: 29880565 DOI: 10.1136/bmjopen-2017-020528] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 7.0] [Reference Citation Analysis]
13 Wendt S, Trawinski H, Pietsch C, Borte M, Lübbert C. [Vaccinations]. Internist (Berl) 2021. [PMID: 34709421 DOI: 10.1007/s00108-021-01193-9] [Reference Citation Analysis]
14 de Boer PT, van Lier A, de Melker H, van Wijck AJM, Wilschut JC, van Hoek AJ, Postma MJ. Cost-effectiveness of vaccination of immunocompetent older adults against herpes zoster in the Netherlands: a comparison between the adjuvanted subunit and live-attenuated vaccines. BMC Med 2018;16:228. [PMID: 30518427 DOI: 10.1186/s12916-018-1213-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
15 Buchan SA, Daneman N, Wang J, Wilson SE, Garber G, Wormsbecker AE, Antoniou T, Deeks SL. Herpes zoster in older adults in Ontario, 2002-2016: Investigating incidence and exploring equity. PLoS One 2021;16:e0246086. [PMID: 33571224 DOI: 10.1371/journal.pone.0246086] [Reference Citation Analysis]
16 Choi WS, Choi JH, Jung DS, Choi HJ, Kim YS, Lee J, Jang HC, Shin EC, Park JS, Kim H, Cheong HJ. Immunogenicity and safety of a new live attenuated herpes zoster vaccine (NBP608) compared to Zostavax® in healthy adults aged 50 years and older. Vaccine 2019;37:3605-10. [PMID: 31122860 DOI: 10.1016/j.vaccine.2019.04.046] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
17 Curran D, Hunjan M, El Ghachi A, El-Hahi Y, Bianco V, Ferreira G. Herpes zoster related healthcare burden and costs in immunocompromised (IC) and IC-free populations in England: an observational retrospective database analysis. BMJ Open 2019;9:e023502. [PMID: 31462457 DOI: 10.1136/bmjopen-2018-023502] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]